These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11386496)

  • 1. Bupropion sustained-release for the treatment of dysthymic disorder: an open-label study.
    Hellerstein DJ; Batchelder S; Kreditor D; Fedak M
    J Clin Psychopharmacol; 2001 Jun; 21(3):325-9. PubMed ID: 11386496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram in the treatment of dysthymic disorder.
    Hellerstein DJ; Batchelder S; Miozzo R; Kreditor D; Hyler S; Gangure D; Clark J
    Int Clin Psychopharmacol; 2004 May; 19(3):143-8. PubMed ID: 15107656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
    Coleman CC; King BR; Bolden-Watson C; Book MJ; Segraves RT; Richard N; Ascher J; Batey S; Jamerson B; Metz A
    Clin Ther; 2001 Jul; 23(7):1040-58. PubMed ID: 11519769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients.
    Reimherr FW; Cunningham LA; Batey SR; Johnston JA; Ascher JA
    Clin Ther; 1998; 20(3):505-16. PubMed ID: 9663366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.
    DeBattista C; Solvason HB; Poirier J; Kendrick E; Schatzberg AF
    J Clin Psychopharmacol; 2003 Feb; 23(1):27-30. PubMed ID: 12544372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.
    Dunner DL; Zisook S; Billow AA; Batey SR; Johnston JA; Ascher JA
    J Clin Psychiatry; 1998 Jul; 59(7):366-73. PubMed ID: 9714265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sustained-release bupropion in neuropathic pain: an open-label study.
    Semenchuk MR; Davis B
    Clin J Pain; 2000 Mar; 16(1):6-11. PubMed ID: 10741812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features.
    Seo HJ; Lee BC; Seok JH; Jeon HJ; Paik JW; Kim W; Kwak KP; Han C; Lee KU; Pae CU
    Pharmacopsychiatry; 2013 Sep; 46(6):221-6. PubMed ID: 23963965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks.
    Croft H; Houser TL; Jamerson BD; Leadbetter R; Bolden-Watson C; Donahue R; Metz A
    Clin Ther; 2002 Apr; 24(4):662-72. PubMed ID: 12017410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion sustained release for bereavement: results of an open trial.
    Zisook S; Shuchter SR; Pedrelli P; Sable J; Deaciuc SC
    J Clin Psychiatry; 2001 Apr; 62(4):227-30. PubMed ID: 11379835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine in the treatment of dysthymia: an open-label study.
    Hellerstein DJ; Batchelder ST; Little SA; Fedak MJ; Kreditor D; Rosenthal J
    J Clin Psychiatry; 1999 Dec; 60(12):845-9. PubMed ID: 10665631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
    Kavoussi RJ; Segraves RT; Hughes AR; Ascher JA; Johnston JA
    J Clin Psychiatry; 1997 Dec; 58(12):532-7. PubMed ID: 9448656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder.
    Hertzberg MA; Moore SD; Feldman ME; Beckham JC
    J Clin Psychopharmacol; 2001 Feb; 21(1):94-8. PubMed ID: 11199956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.
    Bech P; Fava M; Trivedi MH; Wisniewski SR; Rush AJ
    Acta Psychiatr Scand; 2012 Apr; 125(4):342-8. PubMed ID: 22077211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open trial of bupropion SR in adolescent major depression.
    Glod CA; Lynch A; Flynn E; Berkowitz C; Baldessarini RJ
    J Child Adolesc Psychiatr Nurs; 2003; 16(3):123-30. PubMed ID: 14603988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does pretreatment insomnia or anxiety predict acute response to bupropion SR?
    Rush AJ; Carmody TJ; Haight BR; Rockett CB; Zisook S
    Ann Clin Psychiatry; 2005; 17(1):1-9. PubMed ID: 15941026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
    Stewart JW; McGrath PJ; Deliyannides RA; Quitkin FM
    J Psychiatr Pract; 2009 Sep; 15(5):337-45. PubMed ID: 19820552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.